Safety profile of sequential transcatheter chemoembolization with DC Bead™: results of 237 hepatocellular carcinoma (HCC) patients. (Q50179074)

26 February 2018

title

Safety profile of sequential transcatheter chemoembolization with DC Bead™: results of 237 hepatocellular carcinoma (HCC) patients. (English)

1 reference

26 February 2018

main subject

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author

Athanasios D. Marinis

13

1 reference

26 February 2018

author name string

Katerina Malagari

1

1 reference

26 February 2018

Mary Pomoni

2

1 reference

26 February 2018

Themistoklis N Spyridopoulos

3

1 reference

26 February 2018

Hippokratis Moschouris

4

1 reference

26 February 2018

Alexis Kelekis

5

1 reference

26 February 2018

Spyros Dourakis

6

1 reference

26 February 2018

Efthymia Alexopoulou

7

1 reference

26 February 2018

John Koskinas

8

1 reference

26 February 2018

Michalis Angelopoulos

9

1 reference

26 February 2018

John Kornezos

10

1 reference

26 February 2018

Anastasia Pomoni

11

1 reference

26 February 2018

Savvas Tandeles

12

1 reference

26 February 2018

Spyros Rizos

14

1 reference

26 February 2018

Dimitrios Kelekis

15

1 reference

26 February 2018

publication date

24 December 2010

1 reference

26 February 2018

CardioVascular and Interventional Radiology

published in

1 reference

26 February 2018

volume

34

1 reference

26 February 2018

issue

4

1 reference

26 February 2018

page(s)

774-785

1 reference

26 February 2018

https://scigraph.springernature.com/pub.10.1007/s00270-010-0044-3

exact match

0 references

cites work

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00270-010-0044-3

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-010-0044-3

Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-010-0044-3

Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-010-0044-3

A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-010-0044-3

Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-010-0044-3

Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-010-0044-3

Drug-loaded microspheres for the treatment of liver cancer: review of current results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-010-0044-3

Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-010-0044-3

Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-010-0044-3

Chemoembolization of hepatocellular carcinoma with drug eluting beads.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-010-0044-3

Liver abscess after transcatheter oily chemoembolization for hepatic tumors: incidence, predisposing factors, and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-010-0044-3

Ischemic complications of transcatheter arterial chemoembolization in liver malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-010-0044-3

A prospective study regarding the complications of transcatheter intraarterial lipiodol chemoembolization in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-010-0044-3

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-010-0044-3

Acute hepatic failure following transcatheter arterial embolization for the treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-010-0044-3

Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-010-0044-3

Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-010-0044-3

High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-010-0044-3

Efficacy of transarterial targeted treatments on survival of patients with hepatocellular carcinoma. An Italian experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-010-0044-3

Cytolysis following chemoembolization for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-010-0044-3

Postchemoembolisation syndrome – tumour necrosis or hepatocyte injury?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-010-0044-3

Complications associated with transcatheter arterial embolization for hepatic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-010-0044-3

Emphysematous cholecystitis: complication of hepatic artery embolization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-010-0044-3

Anatomic and technical skill factor of gastroduodenal complication in post-transarterial embolization for hepatocellular carcinoma: a retrospective study of 280 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-010-0044-3

Abdominal rash after transarterial chemoembolization via the right inferior phrenic artery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-010-0044-3

Fatal pulmonary complications after arterial embolization with 40-120- micro m tris-acryl gelatin microspheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-010-0044-3

Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-010-0044-3

Ruptured hepatocellular carcinoma as a complication of transarterial oily chemoembolization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-010-0044-3

Spontaneous rupture of hepatocellular carcinoma: a Western experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-010-0044-3

Diaphragmatic weakness after transcatheter arterial chemoembolization of inferior phrenic artery for treatment of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00270-010-0044-3

10.1007/S00270-010-0044-3

21 January 2018

Identifiers

DOI

1 reference

26 February 2018

1 reference

26 February 2018